BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 25286293)

  • 1. High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry.
    Bhattacharya S; Burridge PW; Kropp EM; Chuppa SL; Kwok WM; Wu JC; Boheler KR; Gundry RL
    J Vis Exp; 2014 Sep; (91):52010. PubMed ID: 25286293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primitive cardiac cells from human embryonic stem cells.
    Hudson J; Titmarsh D; Hidalgo A; Wolvetang E; Cooper-White J
    Stem Cells Dev; 2012 Jun; 21(9):1513-23. PubMed ID: 21933026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells.
    Luo XL; Zhang P; Liu X; Huang S; Rao SL; Ding Q; Yang HT
    Pflugers Arch; 2021 Jul; 473(7):991-1007. PubMed ID: 34031754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparative Assessment of Marker Expression Between Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells and the Developing Pig Heart.
    Lauschke K; Volpini L; Liu Y; Vinggaard AM; Hall VJ
    Stem Cells Dev; 2021 Apr; 30(7):374-385. PubMed ID: 33599158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular prion protein identifies bipotential cardiomyogenic progenitors.
    Hidaka K; Shirai M; Lee JK; Wakayama T; Kodama I; Schneider MD; Morisaki T
    Circ Res; 2010 Jan; 106(1):111-9. PubMed ID: 19910576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.
    Uosaki H; Fukushima H; Takeuchi A; Matsuoka S; Nakatsuji N; Yamanaka S; Yamashita JK
    PLoS One; 2011; 6(8):e23657. PubMed ID: 21876760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
    Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
    Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cardiac extracellular matrix supports myocardial lineage commitment of pluripotent stem cells.
    Oberwallner B; Brodarac A; Anić P; Šarić T; Wassilew K; Neef K; Choi YH; Stamm C
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):416-25; discussion 425. PubMed ID: 24778452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA.
    Ban K; Wile B; Kim S; Park HJ; Byun J; Cho KW; Saafir T; Song MK; Yu SP; Wagner M; Bao G; Yoon YS
    Circulation; 2013 Oct; 128(17):1897-909. PubMed ID: 23995537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2 as a surface marker for enrichment of human pluripotent stem cells-derived ventricular cardiomyocytes.
    Liew LC; Poh BM; An O; Ho BX; Lim CYY; Pang JKS; Beh LY; Yang HH; Soh BS
    Stem Cell Res Ther; 2023 Dec; 14(1):367. PubMed ID: 38093391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of contractile cardiomyocytes from human pluripotent stem-cell-derived cardiomyogenic cultures using a human NCX1-EGFP reporter.
    Ovchinnikov DA; Hidalgo A; Yang SK; Zhang X; Hudson J; Mazzone SB; Chen C; Cooper-White JJ; Wolvetang EJ
    Stem Cells Dev; 2015 Jan; 24(1):11-20. PubMed ID: 25075536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes.
    Weber N; Schwanke K; Greten S; Wendland M; Iorga B; Fischer M; Geers-Knörr C; Hegermann J; Wrede C; Fiedler J; Kempf H; Franke A; Piep B; Pfanne A; Thum T; Martin U; Brenner B; Zweigerdt R; Kraft T
    Basic Res Cardiol; 2016 Nov; 111(6):68. PubMed ID: 27743117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of ventricular-like cells derived from NKX2-5
    Yamauchi K; Li J; Morikawa K; Liu L; Shirayoshi Y; Nakatsuji N; Elliott DA; Hisatome I; Suemori H
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1278-1284. PubMed ID: 29175323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells.
    Dubois NC; Craft AM; Sharma P; Elliott DA; Stanley EG; Elefanty AG; Gramolini A; Keller G
    Nat Biotechnol; 2011 Oct; 29(11):1011-8. PubMed ID: 22020386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal impact of substrate mechanics on differentiation of human embryonic stem cells to cardiomyocytes.
    Hazeltine LB; Badur MG; Lian X; Das A; Han W; Palecek SP
    Acta Biomater; 2014 Feb; 10(2):604-12. PubMed ID: 24200714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes.
    Bizy A; Guerrero-Serna G; Hu B; Ponce-Balbuena D; Willis BC; Zarzoso M; Ramirez RJ; Sener MF; Mundada LV; Klos M; Devaney EJ; Vikstrom KL; Herron TJ; Jalife J
    Stem Cell Res; 2013 Nov; 11(3):1335-47. PubMed ID: 24095945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells.
    Nsair A; Schenke-Layland K; Van Handel B; Evseenko D; Kahn M; Zhao P; Mendelis J; Heydarkhan S; Awaji O; Vottler M; Geist S; Chyu J; Gago-Lopez N; Crooks GM; Plath K; Goldhaber J; Mikkola HK; MacLellan WR
    PLoS One; 2012; 7(10):e45603. PubMed ID: 23056209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.
    Burridge PW; Thompson S; Millrod MA; Weinberg S; Yuan X; Peters A; Mahairaki V; Koliatsos VE; Tung L; Zambidis ET
    PLoS One; 2011 Apr; 6(4):e18293. PubMed ID: 21494607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling.
    Kadari A; Mekala S; Wagner N; Malan D; Köth J; Doll K; Stappert L; Eckert D; Peitz M; Matthes J; Sasse P; Herzig S; Brüstle O; Ergün S; Edenhofer F
    Stem Cell Rev Rep; 2015 Aug; 11(4):560-9. PubMed ID: 25392050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.